THE RENOPROTECTIVE EFFECTS OF SODIUM VALPROATE AS A HISTONE DEACETYLASE INHIBITOR ON DIABETIC

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

ATAEE R.; ESMAEELI H.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: JOURNAL OF BABOL UNIVERSITY OF MEDICAL SCIENCES (JBUMS) Year:2017 | Volume:19 | Issue:9 Page(s): 45-53

Download Full-Text

Persian Verion

View:

884

Download:

Cites:

Information Journal Paper

Title

THE RENOPROTECTIVE EFFECTS OF SODIUM VALPROATE AS A HISTONE DEACETYLASE INHIBITOR ON DIABETIC

Author(s)

ATAEE R. | ESMAEELI H. | Issue Writer Certificate

Keywords

SODIUM VALPROATEQ2

DIABETIC NEPHROPATHIESQ2

HISTONE DEACETYLASE INHIBITORSQ1

Abstract

BACKGROUND AND OBJECTIVE: Diabetic nephropathy (DN), as the most common cause of end-stage renal failure, caused by protein kinase C pathway and reactive oxygen species. Recent studies demonstrated importance of epigenetic processes such as histone acetylation and the role of histone deacetylases (HDAC) and histone acetyltransferase in the development of this silent epidemic. SODIUM VALPROATE (VA) is known as a histone deacetylase inhibitor (HDACi). DN must be prevented and treated because it is prevalent and important.METHODS: In this study, scientific articles indexed in databases "Web of science, Scopus, PubMed, SID, ISI" were studied using key words "SODIUM VALPROATE, DIABETIC NEPHROPATHIES, HISTONE DEACETYLASE INHIBITORS".FINDINGS: VA can prevent the degradation podocytes and renal cells through the autophagy and reduce proteinuria in the DN condition. In addition, VA, as an HDAC, prevented apoptosis of podocytes, thus it improves DN. Because HDAC class I involved in renal fibrogenesis and fibroblast activation by modulation of TGF-b signaling, SODIUM VALPROATE promotes antifibrotic effects logically. VA can regulate NF-kB signaling, thereby exert an anti-inflammatory effect in podocytes. HDAC inhibition decreased eNOS mRNA but paradoxically increased activity of eNOS promoter, probably because of inducing an eNOS mRNA-destabilizing factor. SODIUM VALPROATE as a HDACi has the high renoprotective effect in laboratory studies with DN models.CONCLUSION: It is expected that SODIUM VALPROATE will be used as the prevention or treatment of DN in the future after the clinical trials.

Cites

No record.

References

No record.

Cite

APA: Copy

ATAEE, R., & ESMAEELI, H.. (2017). THE RENOPROTECTIVE EFFECTS OF SODIUM VALPROATE AS A HISTONE DEACETYLASE INHIBITOR ON DIABETIC. JOURNAL OF BABOL UNIVERSITY OF MEDICAL SCIENCES (JBUMS), 19(9 ), 45-53. SID. https://sid.ir/paper/73179/en

Vancouver: Copy

ATAEE R., ESMAEELI H.. THE RENOPROTECTIVE EFFECTS OF SODIUM VALPROATE AS A HISTONE DEACETYLASE INHIBITOR ON DIABETIC. JOURNAL OF BABOL UNIVERSITY OF MEDICAL SCIENCES (JBUMS)[Internet]. 2017;19(9 ):45-53. Available from: https://sid.ir/paper/73179/en

IEEE: Copy

R. ATAEE, and H. ESMAEELI, “THE RENOPROTECTIVE EFFECTS OF SODIUM VALPROATE AS A HISTONE DEACETYLASE INHIBITOR ON DIABETIC,” JOURNAL OF BABOL UNIVERSITY OF MEDICAL SCIENCES (JBUMS), vol. 19, no. 9 , pp. 45–53, 2017, [Online]. Available: https://sid.ir/paper/73179/en

Related Journal Papers